Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® Pipeline and Platform
Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® ...
The Pharma Letter19h
Maxion Therapeutics raises $72 million
Cambridge, UK-based biotech start-up Maxion Therapeutics, which is developing antibody-based KnotBody drugs for ion channel- ...
Business Weekly20h
International investors back Maxion Therapeutics in $72m Series A raise
Cambridge biotech Maxion Therapeutics has raised $72 million (£58m) in a Series A financing to further grow the business ...
The Pharma Letter13h
Partners aim to develop new class of obesity therapeutics
Abalone Bio, an antibody company measuring large-scale activity data to drive AI-powered discovery of active therapeutics, ...
Le Lézard18h
Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells
Revelation Biosciences, Inc. (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation to optimize health, announced Gemini priming attenuates ...